pentobarbital will minimize the level or influence of elbasvir/grazoprevir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic result of elbasvir/grazoprevir may very well be reduced if coadministered with powerful CYP3A inducers and it is as a result contraindicated.pentobarbital will decrease the level or im